Jennison Associates
SPTX

Jennison Associates’s Seaport Therapeutics SPTX Stock Holding History

Jennison Associates’s Portfolio SPTX Stock Details SPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5M Buy
+1,079,669
New +$19M 0.01% 319

Other funds holding SPTX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Jennison Associates's SPTX Position: Q2 2026 in Review

Jennison Associates opened a new position in Seaport Therapeutics (SPTX) in Q2 2026: 1,079,669 shares worth $23.5M. The stake represents 0.01% of the portfolio and ranks #319 among its holdings.

5 funds tracked by Wall St. Rank hold SPTX as of Q2 2026.

  • Jennison Associates held 1,079,669 shares of Seaport Therapeutics worth $23.5M as of Q2 2026.
  • Seaport Therapeutics was a new Jennison Associates position in Q2 2026.
  • Seaport Therapeutics made up 0.01% of Jennison Associates's portfolio in Q2 2026, its #319 holding.
  • 5 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.